|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturities, AFS, at fair value (amortized cost of $48,913 and $46,871, and ACL of $19 and $16) | ||||||||||||||||||||
| Fixed maturities, at fair value using the fair value option ("FVO Securities") | ||||||||||||||||||||
| Equity securities, at fair value [1] | ||||||||||||||||||||
| Mortgage loans (net of ACL of $49 and $49) | ||||||||||||||||||||
| Limited partnerships and other alternative investments | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accrued Investment Income Receivable | ||||||||||||||||||||
| Premiums receivable and agents' balances (net of ACL of $165 and $142) | ||||||||||||||||||||
| Reinsurance recoverables (net of allowance for uncollectible reinsurance of $72 and $69) | ||||||||||||||||||||
| Reinsurance recoverables (net of allowance for uncollectible reinsurance of $109 and $105) | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Unpaid losses and loss adjustment expenses | ||||||||||||||||||||
| Liability for Future Policy Benefit, before Reinsurance, Beginning Balance | ||||||||||||||||||||
| Other policyholder funds and benefits payable | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Preferred stock, $0.01 par value — 50,000,000 shares authorized, 13,800 shares issued at September 30, 2026 and December 31, 2025, aggregate liquidation preference of $345 | ||||||||||||||||||||
| Common Stock, Shares Authorized | ||||||||||||||||||||
| Common Stock, Par or Stated Value Per Share | ||||||||||||||||||||
| Common Stock, Value, Issued | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury Stock, Value | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) ("AOCI"), net of tax | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| ACL | ||||||||||||||||||||
| Common Stock, Shares, Issued | ||||||||||||||||||||
| Treasury Stock, Common, Shares | ||||||||||||||||||||
Loading...
